Enabling the fastest & most economical unbiased hit identification

Serengen synthesises and screens DNA-Encoded Libraries (DEL) tailored to your project.

Our proprietary technology offers the fastest and most cost-efficient approach to hit identification that allows for serendipity and delivers high quality hits.

Accelerate early drug discovery

Perform today’s fastest and most economical hit identification and significantly speed up early drug discovery:

PHARMA

Access a unique DEL technology that allows to add a truly novel chemical space to your DEL screening decks.

BIOTECH

Benefit from serendipity in hit ID with a breakthrough DEL technology that offers lower hit attrition and lower follow-up costs.

START-UPS & RESEARCH ORGANISATIONS

Save time and budget by screening DELs that are designed for your target proteins.

Talk to us about flexible business models!

What´s new

Serengen at Nordic Life Science Days 2026 in Stockholm

Serengen at Nordic Life Science Days 2026 in Stockholm 8-9 September 2026 | Kistamässan, Stockholm, Sweden NLSDays is the largest life-science partnering event in the

29th August 2026

BIO-Europe 2023 – November 6-8 in Munich, Germany

Meet us at the BIO-Europe!

23rd October 2023

Deargen and Serengen Partner to Accelerate Drug Discovery

Get ready to take hit ID in drug discovery to the next level! Serengen and Deargen have partnered up to integrate their DEL and AI platforms for a faster, more affordable and effective drug discovery.

29th August 2023